Park, Jiyoon
Djelassi, Malek
Chima, Daniel
Hernandez, Robert
Poroshin, Vladimir
Iliescu, Ana-Maria
Domalik, Douglas
Southall, Noel http://orcid.org/0000-0003-4500-880X
Funding for this research was provided by:
AstraZeneca
Article History
Accepted: 10 October 2023
First Online: 8 November 2023
Declarations
:
: This study was funded by AstraZeneca.
: All authors are employees of AstraZeneca and may hold stock or stock options or restricted shares.
: The datasets generated or analyzed during the current study are available from the corresponding author on reasonable request; proprietary and/or sensitive safety data are not available for disclosure.
: Not applicable.
: Not applicable.
: Not applicable.
: The authors regret that we are unable to share the model prediction software, as it depends on commercial services and proprietary source code.
: Conception and design: DC, RH, VP, AI, DD, and NS. Collection and assembly of data: JP and MD. Data analysis and interpretation: JP, MD, DC, AI, DD, and NS. Manuscript writing: JP, DC, RH, AI, DD, and NS. Accountable for all aspects of the work: All authors.